NewsDialy
Anthropic has released Claude Science, a version of its large language model configured specifically for scientific laboratories and pharmaceutical research operations, becoming the first large artificial intelligence developer to offer a separate interface and product built for scientists.
The company has also disclosed plans to develop its own drugs, treating the new platform as a foothold in a broader competition to shape the future of biology. At the same time, President Trump's effort to make U.S.
prescription drug prices the world's lowest is running up against the realities of mid-sized pharmaceutical companies, whose business models make industry-wide price agreements far harder to strike.
What Claude Science Is and Why Pharma Is the Target Claude Science is Anthropic's answer to a specific demand: pharmaceutical and scientific research teams need AI tools calibrated for laboratory workflows, not general conversation.
Keep reading